IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Por um escritor misterioso
Last updated 26 dezembro 2024
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses - ScienceDirect
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
EMDB < EMD-25663
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Frontiers Nanobodies: COVID-19 and Future Perspectives
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances

© 2014-2024 atsrb.gos.pk. All rights reserved.